Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

43.34USD
22 Jul 2019
Change (% chg)

-- (--)
Prev Close
$43.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
202,281
52-wk High
$60.98
52-wk Low
$36.19

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 145.42 3.071
FY 2018 Dec '18 0.00 -2.239
Sep '18 0.00 -1.862
Jun '18 0.00 -1.707
Mar '18 0.00 -1.734
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 11 0.90 1.53 0.00 0.00
Quarter Ending Dec-19 11 0.90 1.53 0.00 0.00
Year Ending Dec-19 10 148.41 150.00 145.42 27.78
Year Ending Dec-20 11 181.02 236.10 86.62 47.44
Earnings (per share)
Quarter Ending Sep-19 11 -1.80 -1.47 -2.15 -1.35
Quarter Ending Dec-19 11 -1.92 -1.51 -2.56 -1.34
Year Ending Dec-19 10 -2.45 -1.60 -3.65 -5.33
Year Ending Dec-20 11 -3.05 -0.68 -6.99 -6.52
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.41 32.67
P/E High - Last 5 Yrs. -- 147.75 47.29
P/E Low - Last 5 Yrs. -- 48.01 23.88
Beta 2.67 1.09 0.89
Price to Sales (TTM) -- 49.46 7.92
Price to Book (MRQ) 8.24 10.14 5.39
Price to Tangible Book (MRQ) 9.37 13.75 6.71
Price to Cash Flow (TTM) -- 55.97 24.37
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.00 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.69 12.24
Sales (TTM) vs TTM 1 Yr. Ago -- 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.81 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -208.10 75.26 43.01
EPS (TTM) vs TTM 1 Yr. Ago -138.27 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate 22.82 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 5.52 3.59 3.03
LT Debt to Equity (MRQ) 0.09 18.58 10.21
Total Debt to Equity (MRQ) 1.24 31.20 14.56
Interest Coverage (TTM) -120.23 -43.39 29.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.07 52.21
Gross Margin - 5 Yr. Avg. -- 60.31 50.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.44 13.16
Operating Margin (TTM) -- -184.27 6.88
Operating Margin - 5 Yr. Avg. -- -126.89 8.97
Pre-Tax Margin (TTM) -- -175.02 6.08
Pre-Tax Margin - 5 Yr. Avg. -- -132.65 9.26
Net Profit Margin (TTM) -- -181.72 2.72
Net Profit Margin - 5 Yr. Avg. -- -137.02 5.63
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,672,423 887,716,663
Net Income/Employee (TTM) -2,959,909 533,977 101,894,138
Receivable Turnover (TTM) -- 6.28 5.94
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.00 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.29 6.42 11.18
Return on Assets - 5 Yr. Avg. -30.70 5.51 12.34
Return on Investment (TTM) -61.42 8.94 14.49
Return on Investment - 5 Yr. Avg. -32.77 6.84 16.03
Return on Equity (TTM) -61.71 10.07 15.79
Return on Equity - 5 Yr. Avg. -35.99 8.42 17.02
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -47.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.55 7.70 99 99
13 Week 20.24 14.38 99 95
26 Week 56.92 44.99 99 97
52 Week 315.45 252.13 99 70
YTD 348.96 294.28 99 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 209
Total Shares Held: 29,586,100
3 Mo. Net Change: -39,946
# New Positions: 5
# Closed Positions: 6
# Increased Positions: 7
# Reduced Positions: 14
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.